Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Biomarkers in idiopathic pulmonary fibrosis.
Drakopanagiotakis F, Wujak L, Wygrecka M, Markart P. Drakopanagiotakis F, et al. Matrix Biol. 2018 Aug;68-69:404-421. doi: 10.1016/j.matbio.2018.01.023. Epub 2018 Jan 31. Matrix Biol. 2018. PMID: 29408012 Review.
Intraindividual response to treatment with pirfenidone in idiopathic pulmonary fibrosis.
Loeh B, Drakopanagiotakis F, Bandelli GP, von der Beck D, Tello S, Cordani E, Rizza E, Barrocu L, Markart P, Seeger W, Guenther A, Albera C. Loeh B, et al. Among authors: drakopanagiotakis f. Am J Respir Crit Care Med. 2015 Jan 1;191(1):110-3. doi: 10.1164/rccm.201406-1106LE. Am J Respir Crit Care Med. 2015. PMID: 25551350 No abstract available.
[Antifibrotic treatment].
von der Beck D, Löh B, Drakopanagiotakis F, Markart P, Günther A. von der Beck D, et al. Among authors: drakopanagiotakis f. Dtsch Med Wochenschr. 2014 Dec;139(49):2523-5. doi: 10.1055/s-0034-1387450. Epub 2014 Nov 25. Dtsch Med Wochenschr. 2014. PMID: 25423462 Review. German. No abstract available.
The European IPF registry (eurIPFreg): baseline characteristics and survival of patients with idiopathic pulmonary fibrosis.
Guenther A, Krauss E, Tello S, Wagner J, Paul B, Kuhn S, Maurer O, Heinemann S, Costabel U, Barbero MAN, Müller V, Bonniaud P, Vancheri C, Wells A, Vasakova M, Pesci A, Sofia M, Klepetko W, Seeger W, Drakopanagiotakis F, Crestani B. Guenther A, et al. Among authors: drakopanagiotakis f. Respir Res. 2018 Jul 28;19(1):141. doi: 10.1186/s12931-018-0845-5. Respir Res. 2018. PMID: 30055613 Free PMC article.
Exploring the Ability of Electronic Nose Technology to Recognize Interstitial Lung Diseases (ILD) by Non-Invasive Breath Screening of Exhaled Volatile Compounds (VOC): A Pilot Study from the European IPF Registry (eurIPFreg) and Biobank.
Krauss E, Haberer J, Maurer O, Barreto G, Drakopanagiotakis F, Degen M, Seeger W, Guenther A. Krauss E, et al. Among authors: drakopanagiotakis f. J Clin Med. 2019 Oct 16;8(10):1698. doi: 10.3390/jcm8101698. J Clin Med. 2019. PMID: 31623141 Free PMC article.
Acute exacerbations of interstitial lung diseases.
Papanikolaou IC, Drakopanagiotakis F, Polychronopoulos VS. Papanikolaou IC, et al. Among authors: drakopanagiotakis f. Curr Opin Pulm Med. 2010 Sep;16(5):480-6. doi: 10.1097/MCP.0b013e32833ae49d. Curr Opin Pulm Med. 2010. PMID: 20473169 Review.
34 results